COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression.

TitleCOX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression.
Publication TypeJournal Article
Year of Publication2003
AuthorsSymensma TL, Martinez-Guzman DA, Jia Q, Bortz E, Wu T-T, Rudra-Ganguly N, Cole S, Herschman H, Sun R
JournalJ Virol
Volume77
Issue23
Pagination12753-63
Date Published2003 Dec
ISSN0022-538X
KeywordsAnimals, Cell Line, Cricetinae, Cyclooxygenase 2, Dinoprostone, Enzyme Induction, Gammaherpesvirinae, Gene Expression Regulation, Viral, Genes, Viral, Herpesviridae Infections, Indomethacin, Isoenzymes, Mice, Nitrobenzenes, Oligonucleotide Array Sequence Analysis, Prostaglandin-Endoperoxide Synthases, Sulfonamides
Abstract

The murine gammaherpesvirus 68 (MHV-68 or gammaHV-68) model provides many advantages for studying virus-host interactions involved in gammaherpesvirus replication, including the role of cellular responses to infection. We examined the effects of cellular cyclooxygenase-2 (COX-2) and its by-product prostaglandin E(2) (PGE(2)) on MHV-68 gene expression and protein production following de novo infection of cultured cells. Western blot analyses revealed an induction of COX-2 protein in MHV-68-infected cells but not in cells infected with UV-irradiated MHV-68. Luciferase reporter assays demonstrated activation of the COX-2 promoter during MHV-68 replication. Two nonsteroidal anti-inflammatory drugs, a COX-2-specific inhibitor (NS-398) and a COX-1-COX-2 inhibitor (indomethacin), substantially reduced MHV-68 protein production in infected cells. Inhibition of viral protein expression and virion production by NS-398 was reversed in the presence of exogenous PGE(2). Global gene expression analysis using an MHV-68 DNA array showed that PGE(2) increased production of multiple viral gene products, and NS-398 inhibited production of many of the same genes. These studies suggest that COX-2 activity and PGE(2) production may play significant roles during MHV-68 de novo infection.

Alternate JournalJ. Virol.
PubMed ID14610197
PubMed Central IDPMC262602
Grant ListAI-AI50495 / AI / NIAID NIH HHS / United States
AI49135 / AI / NIAID NIH HHS / United States
AI52737 / AI / NIAID NIH HHS / United States
CA83525 / CA / NCI NIH HHS / United States
CA91791 / CA / NCI NIH HHS / United States
DE14153 / DE / NIDCR NIH HHS / United States
F32 CA88517 / CA / NCI NIH HHS / United States